The timing of reperfusion therapy
Bernard J Gersh
This article has no abstract so we have provided the first paragraph of the full text.
A fundamental tenet of reperfusion therapy is that 'time is muscle', since ischemia leading to necrosis is progressive. Regardless of whether treatment is pharmacologic or primary percutaneous coronary intervention (PCI), evidence is accumulating that delays at each stage in the process are associated with adverse outcomes. Indeed, the ability to deliver therapy expeditiously is generally accepted as a surrogate for quality of care.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
